Healthy volunteers to test new inhaled compound in Early-Stage safety study
NCT ID NCT07540494
First seen Apr 21, 2026 · Last updated May 08, 2026 · Updated 2 times
Summary
This early-stage study will give a single dose of an investigational drug called GH001 to 12 healthy adults using a special inhaler. Researchers will measure how the drug moves through the body and check for any side effects. The goal is to gather safety and drug-level information, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
GH Research Clinical Trial Site
Miami, Florida, 33319, United States
Contact
Conditions
Explore the condition pages connected to this study.